BY Benjamin ClarkJune 19, 2025
10 months ago
BY 
 | June 19, 2025
10 months ago

Supreme Court backs Tennessee ban on youth gender procedures

The U.S. Supreme Court upheld a Tennessee law Wednesday that restricts gender-transition-related medical treatments for minors, marking one of the most significant rulings yet in the national debate over transgender healthcare access.

In a 6–3 decision, the Court determined that Tennessee’s Senate Bill 1 does not violate constitutional equal protection rights, keeping in place restrictions on gender-transition care for children and teens, the Christian Post reported.

The law, passed by the Tennessee General Assembly in March 2023, prohibits healthcare professionals from providing certain gender-related medical treatments to individuals under 18. Specifically, it bans surgeries altering the genitalia and the prescribing of hormones or puberty blockers when intended to treat gender dysphoria.

Tennessee Law Applies Equally to All Minors

Senate Bill 1 only limits the use of these treatments when they are associated with gender identity conditions. The law does permit puberty blockers and hormones when used for other medical conditions not related to gender transition.

Chief Justice John Roberts authored the majority opinion, joined by Justices Clarence Thomas, Neil Gorsuch, Brett Kavanaugh, and Amy Coney Barrett. Justice Samuel Alito concurred separately in the judgment.

Roberts argued that the law treats all minors the same regardless of sex. He wrote that no minor, male or female, may receive hormone therapy or puberty blockers for gender identity-related diagnoses under this law.

Majority Cites State's Interest in Child Welfare

The chief justice emphasized that Tennessee has a substantial interest in safeguarding the physical and emotional well-being of minors. He referred to the treatments as potentially dangerous, invoking concerns about regret and the permanence of such decisions made in adolescence.

Roberts cited international developments to support the ruling, noting the United Kingdom's decision to prohibit these same treatments for minors outside of approved clinical trials. He stated this ban illustrates the serious public health concerns at stake.

“This case touches on serious debates in science and policy,” Roberts wrote. “But the Constitution does not give this Court the role to settle those disputes. That belongs to the people and their elected officials.”

Dissenting Opinion Alleges Discrimination

Justice Sonia Sotomayor dissented, joined by Justice Ketanji Brown Jackson and partially by Justice Elena Kagan. Sotomayor argued the law unfairly targets youth based on both sex and transgender status.

She criticized the majority for applying a relatively weak legal standard to evaluate the law's constitutionality. In her view, more rigorous scrutiny should have been applied to a statute that affects a specific group’s access to medical care.

"The Court turns away from essential judicial review," Sotomayor wrote. "By doing so, it leaves transgender youth and their families at the mercy of shifting politics.”

Legal Challenge and Federal Involvement

The case, United States v. Skrmetti, began after several advocacy groups and families of transgender-identifying minors challenged the law with support from the U.S. Justice Department under the Biden administration. The plaintiffs argued that the law discriminated and would cause harm to transgender youth.

Although a district court initially blocked the legislation from taking effect, the 6th U.S. Circuit Court of Appeals reversed that decision in September 2023. Chief Judge Jeffrey Sutton, writing for the appellate panel, supported the state’s reasoning in defending the law.

The Supreme Court agreed to hear the case and held oral arguments in December 2023. At the time, U.S. Solicitor General Elizabeth Prelogar contended the law was discriminatory but conceded that states hold some right to regulate treatments in this area.

Shift in Federal Position Influenced Outcome

In February 2025, the Trump administration withdrew federal support for the lawsuit. That change in stance followed the administration's broader approach to limiting federal influence on state-level decisions on medical and educational policies.

Senate Bill 1 itself declares that the state sought to shield the medical profession from performing what it described as experimental and potentially unethical procedures. The legislation frames its aims as protecting integrity and preventing psychological and physical harm to youth.

This week’s ruling marks the highest court's first significant interpretation of a state-level restriction on gender-transition care for minors, likely influencing similar laws around the country.

Written by: Benjamin Clark
Benjamin Clark delivers clear, concise reporting on today’s biggest political stories.

NATIONAL NEWS

SEE ALL

Cincinnati fires police chief who refused to put more officers on the street as violent crime surged

Cincinnati City Manager Sheryl Long fired Police Chief Teresa Theetge on April 24, stripping the city's first female police chief of her badge after concluding…
17 hours ago
 • By Bishop Shepard

Fifth Circuit backs Texas law requiring Ten Commandments in public school classrooms

The Fifth Circuit Court of Appeals upheld a Texas law requiring every public school classroom in the state to display a copy of the Ten…
17 hours ago
 • By Sarah Whitman

Prosecutors allege child pornography found on singer D4vd's phone as murder trial looms

Prosecutors told a Los Angeles court Thursday morning that singer D4vd's cellphone contained a "significant amount" of child pornography, a claim that surfaced amid an…
17 hours ago
 • By Steven Terwilliger

Iran's new supreme leader reportedly awaits prosthetic leg and facial surgery after U.S. airstrike wounds

Ayatollah Mojtaba Khamenei, the son who inherited Iran's supreme leadership after the death of his father, has not appeared in public since the war began,…
2 days ago
 • By Steven Terwilliger

Regeneron becomes 17th drugmaker to accept Trump's most-favored-nation pricing terms

President Donald Trump announced from the Oval Office that Regeneron has agreed to offer its prescription medications at most-favored-nation prices, completing a sweep of 17…
2 days ago
 • By Bishop Shepard

Newsletter

Get news from American Digest in your inbox.

    By submitting this form, you are consenting to receive marketing emails from: American Digest, 3000 S. Hulen Street, Ste 124 #1064, Fort Worth, TX, 76109, US, http://americandigest.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact.
    Christian News Alerts is a conservative Christian publication. Share our articles to help spread the word.
    © 2026 - CHRISTIAN NEWS ALERTS - ALL RIGHTS RESERVED
    magnifier